Overview Money In Money Out People Positions Interview Endorsements
About To explore, demonstrate and communicate - through research, partnership and education - the role and value of innovative biopharmaceuticals to achieve better patient health.
Donations are NOT tax-deductible
Category
Trade Association
Learn More ▾
Financial Snapshot FY ending 2023-12-31 Financial history 16 17 18 19 20 21 22 23
Revenue Expenses
Latest FY2023: $11.0M · Avg: $9.6M
NATIONAL PHARMACEUTICAL COUNCIL INC
Address 1717 Pennsylvania AVE NW STE 800
Washington, DC, 20006-466
Governance Voting board members 20
Independent members 20
Conflict-of-interest policy Yes
Whistleblower policy Yes
Doc-retention policy Yes
Audit committee Yes
990 reviewed by board No
Compensation practices Severance payments No
Equity-based comp No
Supplemental retirement plan No
Used comp survey Yes
Board approved comp Yes
Public records
These open in a new tab. AllCiv doesn't host filings directly — these are the authoritative public-record sources.